These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18626954)

  • 1. Optimization of the hydroxylamine cleavage of an expressed fusion protein to produce recombinant human insulin-like growth factor (IGF)-I.
    Milner SJ; Thomas SM; Ballard FJ; Francis GL
    Biotechnol Bioeng; 1996 May; 50(3):265-72. PubMed ID: 18626954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two chemical cleavage methods for preparation of a truncated form of recombinant human insulin-like growth factor I from a secreted fusion protein.
    Forsberg G; Baastrup B; Brobjer M; Lake M; Jörnvall H; Hartmanis M
    Biofactors; 1989 Dec; 2(2):105-12. PubMed ID: 2696476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylamine-induced cleavage of the asparaginyl-glycine motif in the production of recombinant proteins: the case of insulin-like growth factor I.
    Antorini M; Breme U; Caccia P; Grassi C; Lebrun S; Orsini G; Taylor G; Valsasina B; Marengo E; Todeschini R; Andersson C; Gellerfors P; Gustafsson JG
    Protein Expr Purif; 1997 Oct; 11(1):135-47. PubMed ID: 9325149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical heterogeneity as a result of hydroxylamine cleavage of a fusion protein of human insulin-like growth factor I.
    Canova-Davis E; Eng M; Mukku V; Reifsnyder DH; Olson CV; Ling VT
    Biochem J; 1992 Jul; 285 ( Pt 1)(Pt 1):207-13. PubMed ID: 1637301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of recombinant insulin-like growth factor-I (IGF-I) and potent analogues of IGF-I, with Gly or Arg substituted for Glu3, following their expression in Escherichia coli as fusion proteins.
    King R; Wells JR; Krieg P; Snoswell M; Brazier J; Bagley CJ; Wallace JC; Ballard FJ; Ross M; Francis GL
    J Mol Endocrinol; 1992 Feb; 8(1):29-41. PubMed ID: 1311930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I (IGF-I): solution properties and NMR chemical shift assignments near physiological pH.
    Kuang Z; Yao S; McNeil KA; Forbes BE; Wallace JC; Norton RS
    Growth Horm IGF Res; 2009 Jun; 19(3):226-31. PubMed ID: 19056307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra scale-down of protein refold screening in microwells: challenges, solutions and application.
    Mannall GJ; Myers JP; Liddell J; Titchener-Hooker NJ; Dalby PA
    Biotechnol Bioeng; 2009 Jun; 103(2):329-40. PubMed ID: 19160381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression and simple purification of recombinant human insulin-like growth factor I.
    Kim SO; Lee YI
    J Biotechnol; 1996 Jul; 48(1-2):97-105. PubMed ID: 8818276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and characterization of insulin growth factor-I-enhanced green fluorescent protein fused protein as a tracer for immunoassay.
    Shi R; Huang Y; Wang D; Zhao M; Li Y
    Anal Chim Acta; 2006 Sep; 578(2):131-6. PubMed ID: 17723704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct production of proteins with N-terminal cysteine for site-specific conjugation.
    Gentle IE; De Souza DP; Baca M
    Bioconjug Chem; 2004; 15(3):658-63. PubMed ID: 15149194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification.
    Moks T; Abrahmsén L; Holmgren E; Bilich M; Olsson A; Uhlén M; Pohl G; Sterky C; Hultberg H; Josephson S
    Biochemistry; 1987 Aug; 26(17):5239-44. PubMed ID: 3676250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational study on nonenzymatic peptide bond cleavage at asparagine and aspartic acid.
    Catak S; Monard G; Aviyente V; Ruiz-López MF
    J Phys Chem A; 2008 Sep; 112(37):8752-61. PubMed ID: 18714962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refolding of Npro fusion proteins.
    Kaar W; Ahrer K; Dürauer A; Greinstetter S; Sprinzl W; Wechner P; Clementschitsch F; Bayer K; Achmüller C; Auer B; Hahn R; Jungbauer A
    Biotechnol Bioeng; 2009 Nov; 104(4):774-84. PubMed ID: 19591193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli.
    Qian ZG; Xia XX; Choi JH; Lee SY
    Biotechnol Bioeng; 2008 Oct; 101(3):587-601. PubMed ID: 18727129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of mechano-growth factor in Escherichia coli and activity analysis].
    Zhang B; Jiang P; Xian C; Li Y; Li D; Tang L; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1180-5. PubMed ID: 18837392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
    Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
    Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtiter plate-based screening for the optimization of DNA-protein conjugate synthesis by means of expressed protein ligation.
    Lovrinovic M; Niemeyer CM
    Chembiochem; 2007 Jan; 8(1):61-7. PubMed ID: 17121402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich alpha-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration.
    Kay RG; Barton C; Velloso CP; Brown PR; Bartlett C; Blazevich AJ; Godfrey RJ; Goldspink G; Rees R; Ball GR; Cowan DA; Harridge SD; Roberts J; Teale P; Creaser CS
    Rapid Commun Mass Spectrom; 2009 Oct; 23(19):3173-82. PubMed ID: 19718777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression and purification of the second transmembrane domain of wild-type and mutant human melanocortin-4 receptor for solid-state NMR structural studies.
    Park TJ; Choi SS; Gang GA; Kim Y
    Protein Expr Purif; 2008 Dec; 62(2):139-45. PubMed ID: 18809499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.